Back to search
FDAFDA · Food and drugs·Recall number D-0507-2024

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

Published May 29, 2024 · Recall initiated: May 13, 2024

Summary

FDA records drug Class II recall D-0507-2024, published May 29, 2024 and initiated May 13, 2024. Recalling firm: American Regent, Inc.; Status: Terminated; Reported quantity: 2,352 vials; Lot: Lot #: 23061L1C0, Exp 1/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent product in addition to having out-of-specification results for impurities.

What to do

Voluntary: Firm initiated · Letter

Get an email if VASOPRESSIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VASOPRESSIN
Manufacturer
American Regent, Inc.
Distributor
USA Nationwide
UPC
0305171030017
Lot
Lot #: 23061L1C0, Exp 1/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01 recalled?

Yes. FDA published recall D-0507-2024 on May 29, 2024. Reported hazard: Subpotent product in addition to having out-of-specification results for impurities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VASOPRESSIN. UPC: 0305171030017.